{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:53:35Z","timestamp":1793012015683,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chemistry Central Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13065-018-0479-1","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T01:46:05Z","timestamp":1541036765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents"],"prefix":"10.1186","volume":"12","author":[{"given":"Fawzia Faleh","family":"Al-blewi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshal A.","family":"Almehmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Reda","family":"Aouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa K.","family":"Bardaweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouslim","family":"Messali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadjet","family":"Rezki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Sayed H.","family":"El Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"479_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1271\/bbb.70.1060","volume":"70","author":"H Yoneyama","year":"2006","unstructured":"Yoneyama H, Katsumata R (2006) Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem 70:1060\u20131075. \n                    https:\/\/doi.org\/10.1271\/bbb.70.1060","journal-title":"Biosci Biotechnol Biochem"},{"key":"479_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","volume":"71","author":"D Dheer","year":"2017","unstructured":"Dheer D, Singh V, Shankar R (2017) Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem 71:30\u201354. \n                    https:\/\/doi.org\/10.1016\/j.bioorg.2017.01.010","journal-title":"Bioorg Chem"},{"key":"479_CR3","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","volume":"143","author":"HM Faidallah","year":"2018","unstructured":"Faidallah HM, Girgis AS, Tiwari AD, Thomas Honkanadavar HH, Samir A et al (2018) Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates. Eur J Med Chem 143:1524\u20131534. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.042","journal-title":"Eur J Med Chem"},{"key":"479_CR4","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.bmc.2011.02.007","volume":"19","author":"AK Jordao","year":"2011","unstructured":"Jordao AK, Ferreira VF, Souza TM, Faria GG, Machado V, Abrantes JL et al (2011) Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives. Bioorg Med Chem 19:1860\u20131865. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2011.02.007","journal-title":"Bioorg Med Chem"},{"key":"479_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C4OB01758G","volume":"13","author":"ZC Dai","year":"2015","unstructured":"Dai ZC, Chen YF, Zhang M, Li SK, Yang TT, Shen L et al (2015) Synthesis and antifungal activity of 1,2,3-triazole phenylhydrazone derivatives. Org Biomol Chem 13:477\u2013486. \n                    https:\/\/doi.org\/10.1039\/C4OB01758G","journal-title":"Org Biomol Chem"},{"key":"479_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/cbdd.12321","volume":"84","author":"N Boechat","year":"2014","unstructured":"Boechat N, Ferreira Mde L, Pinheiro LC, Jesus AM, Leite MM, J\u00fanior CC et al (2014) New compounds hybrids 1H-1,2,3-triazole-quinoline against Plasmodium falciparum. Chem Biol Drug Des 84:325\u2013332. \n                    https:\/\/doi.org\/10.1111\/cbdd.12321","journal-title":"Chem Biol Drug Des"},{"key":"479_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/anie.200502161","volume":"45","author":"M Whiting","year":"2006","unstructured":"Whiting M, Muldoon J, Lin YC, Silverman SM, Lindstron W, Olson AJ et al (2006) Inhibitors of HIV-1 protease by using in situ click chemistry. Angew Chem Int Ed 45:1435\u20131439. \n                    https:\/\/doi.org\/10.1002\/anie.200502161","journal-title":"Angew Chem Int Ed"},{"key":"479_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/jm00356a025","volume":"26","author":"DR Buckle","year":"1983","unstructured":"Buckle DR, Outred DJ, Rockell CJM, Smith H, Spicer BA (1983) Studies on v-Triazoles. 7. Antiallergic 9-Oxo-1H, 9H-benzopyrano [2,3-d]-v\u2013triazoles. J Med Chem 26:251\u2013254. \n                    https:\/\/doi.org\/10.1021\/jm00356a025","journal-title":"J Med Chem"},{"key":"479_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","volume":"138","author":"S Zhang","year":"2017","unstructured":"Zhang S, Xu Z, Gao C, Ren QC, Chang L, Lv ZS et al (2017) Triazole derivatives and their anti-tubercular activity. Eur J Med Chem 138:501\u2013513. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.051","journal-title":"Eur J Med Chem"},{"key":"479_CR10","first-page":"423","volume":"5","author":"JD Shukla","year":"2015","unstructured":"Shukla JD, Khan PMAA, Deo K (2015) Synthesis and pharmacological evaluation of novel 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole derivatives for CNS depressant and anticonvulsant profile. Am J Pharm Tech Res 5:423\u2013433","journal-title":"Am J Pharm Tech Res"},{"key":"479_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2478\/v10007-009-0026-7","volume":"59","author":"A Rajasekaran","year":"2009","unstructured":"Rajasekaran A, Rajagopal KA (2009) Synthesis of some novel triazole derivatives as anti-nociceptive and anti-inflammatory agents. Acta Pharm 59:355\u2013364. \n                    https:\/\/doi.org\/10.2478\/v10007-009-0026-7","journal-title":"Acta Pharm"},{"key":"479_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1389557516666160118105505","volume":"16","author":"EM Nassar","year":"2016","unstructured":"Nassar EM, Abdelrazek FM, Ayyad RR, El-Farargy AF (2016) Synthesis and some reactions of 1-aryl-4-acetyl-5-methyl-1,2,3-triazole derivatives with anticonvulsant activity. Mini Rev Med Chem 16:926\u2013936. \n                    https:\/\/doi.org\/10.2174\/1389557516666160118105505","journal-title":"Mini Rev Med Chem"},{"key":"479_CR13","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1016\/j.tetlet.2011.08.154","volume":"52","author":"MK Reddy","year":"2011","unstructured":"Reddy MK, Kumar KS, Sreenivas P, Krupadanam GLD, Reddy KJ (2011) Synthesis of novel 1,4-disubstituted-1,2,3-triazole semi synthetic analogues of forskolin by click reaction. Tetrahedron Lett 52:6537\u20136540. \n                    https:\/\/doi.org\/10.1016\/j.tetlet.2011.08.154","journal-title":"Tetrahedron Lett"},{"key":"479_CR14","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1039\/C5MD00219B","volume":"6","author":"NR Penthala","year":"2015","unstructured":"Penthala NR, Madhukuri L, Thakkar S, Madadi NR, Lamture G, Eoff RL et al (2015) Synthesis and anti-cancer screening of novel heterocyclic-(2H)- 1,2,3-triazoles as potential anti-cancer agents. Med Chem Commun 6:1535\u20131543. \n                    https:\/\/doi.org\/10.1039\/C5MD00219B","journal-title":"Med Chem Commun"},{"key":"479_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejmech.2016.08.031","volume":"124","author":"R Kant","year":"2016","unstructured":"Kant R, Singh V, Nath G, Awasthi SK, Agarwal A (2016) Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents. Eur J Med Chem 124:218\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.031","journal-title":"Eur J Med Chem"},{"key":"479_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.ejmech.2016.11.028","volume":"125","author":"T Gregori\u0107","year":"2017","unstructured":"Gregori\u0107 T, Sedi\u0107 M, Grb\u010di\u0107 P, Paravi\u0107 AT, Paveli\u0107 SK, Cetina M et al (2017) Novel pyrimidine-2,4-dione\u20131,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: synthesis, computational and X-ray analysis and biological evaluation. Eur J Med Chem 125:1247\u20131267. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2016.11.028","journal-title":"Eur J Med Chem"},{"key":"479_CR17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/ardp.201400142","volume":"347","author":"A Ouahrouch","year":"2014","unstructured":"Ouahrouch A, Ighachane H, Taourirte M, Engels JW, Sedra MH, Lazrek HB (2014) Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and evaluation for antibacterial\/antifungal activity. Arch Pharm 347:748\u2013755. \n                    https:\/\/doi.org\/10.1002\/ardp.201400142","journal-title":"Arch Pharm"},{"key":"479_CR18","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.bmcl.2017.07.023","volume":"27","author":"Z Xu","year":"2017","unstructured":"Xu Z, Zhang S, Song X, Qiang M, Lv Z (2017) Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids. Bioorg Med Chem Lett 27:3643\u20133646. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.023","journal-title":"Bioorg Med Chem Lett"},{"key":"479_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ejmech.2014.06.048","volume":"83","author":"S Sharma","year":"2014","unstructured":"Sharma S, Saquib M, Verma S, Mishra NN, Shukla PK, Srivastava R et al (2014) Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents. Eur J Med Chem 83:474\u2013548. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2014.06.048","journal-title":"Eur J Med Chem"},{"key":"479_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ejmech.2017.11.090","volume":"143","author":"X Yan","year":"2018","unstructured":"Yan X, Lv Z, Wen J, Zhao S, Xu Z (2018) Synthesis and in\u00a0vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities. Eur J Med Chem 143:899\u2013904. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.090","journal-title":"Eur J Med Chem"},{"key":"479_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ejmech.2016.12.010","volume":"138","author":"W Akhtar","year":"2017","unstructured":"Akhtar W, Khan MF, Verma G, Shaquiquzzaman M, Rizvi MA, Mehdi SH et al (2017) Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. Eur J Med Chem 138:705\u2013753. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2016.12.010","journal-title":"Eur J Med Chem"},{"key":"479_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2015.06.016","volume":"121","author":"CW Evans","year":"2015","unstructured":"Evans CW, Atkins C, Pathak A, Gilbert BE, Noah JW (2015) Benzimidazole analogs inhibit respiratory syncytial virus G protein function. Antiviral Res 121:31\u201338. \n                    https:\/\/doi.org\/10.1016\/j.antiviral.2015.06.016","journal-title":"Antiviral Res"},{"key":"479_CR23","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.2174\/1568026616666160506130226","volume":"16","author":"Z Ates-Alagoz","year":"2016","unstructured":"Ates-Alagoz Z (2016) Antimicrobial activities of 1H-benzimidazole-based molecules. Curr Top Med Chem 16:2953\u20132962. \n                    https:\/\/doi.org\/10.2174\/1568026616666160506130226","journal-title":"Curr Top Med Chem"},{"key":"479_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejmech.2017.06.035","volume":"138","author":"P Sharma","year":"2017","unstructured":"Sharma P, Reddy TS, Kumar NP, Senwar KP, Bhargava SK, Shankaraiah N (2017) Conventional and microwave-assisted synthesis of new 1H-benzimidazole-thiazolidinedione derivatives: a potential antiproliferative scaffold. Eur J Med Chem 138:234\u2013245. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.035","journal-title":"Eur J Med Chem"},{"key":"479_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jscs.2011.03.005","volume":"17","author":"MC Sharma","year":"2013","unstructured":"Sharma MC, Sharma S, Sahu NK, Kohli DV (2013) 3D QSAR kNN-MFA studies on 6-substituted benzimidazoles derivatives as nonpeptide angiotensin II receptor antagonists: a rational approach to anti-hypertensive agents. J Saudi Chem Soc 17:167\u2013176. \n                    https:\/\/doi.org\/10.1016\/j.jscs.2011.03.005","journal-title":"J Saudi Chem Soc"},{"key":"479_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.apsb.2015.05.003","volume":"B5","author":"M Gabaa","year":"2015","unstructured":"Gabaa M, Gabaa P, Uppala D, Dhingrac N, Bahiad MS, Silakarid O et al (2015) Benzimidazole derivatives: search for GI-friendly anti-inflammatory analgesic agents. Acta Pharm Sin B5:337\u2013342. \n                    https:\/\/doi.org\/10.1016\/j.apsb.2015.05.003","journal-title":"Acta Pharm Sin"},{"key":"479_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bioorg.2014.12.003","volume":"58","author":"SAH El-Feky","year":"2015","unstructured":"El-Feky SAH, El-Samii ZKA, Osman NA, Lashine J, Kamel MA, Thabet HK (2015) Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II. Bioorg Chem 58:104\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.bioorg.2014.12.003","journal-title":"Bioorg Chem"},{"key":"479_CR28","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1021\/acs.jmedchem.7b00108","volume":"60","author":"P Picconi","year":"2017","unstructured":"Picconi P, Hind C, Jamshidi S, Nahar K, Clifford M, Wand ME et al (2017) Triarylbenzimidazoles as a new class of antibacterial agents against resistant pathogenic microorganisms. J Med Chem 60:6045\u20136059. \n                    https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00108","journal-title":"J Med Chem"},{"key":"479_CR29","first-page":"344","volume":"3","author":"S Lingala","year":"2011","unstructured":"Lingala S, Nerella R, SambasivaRao KRS (2011) Synthesis, antimicrobial and anthelmintic activity of some novel benzimidazole derivatives. Der Pharma Chemica 3:344\u2013352","journal-title":"Der Pharma Chemica"},{"key":"479_CR30","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/molecules22101642","volume":"22","author":"CT Supuran","year":"2017","unstructured":"Supuran CT (2017) Special issue: sulfonamides. Molecules 22:1642\u20131646. \n                    https:\/\/doi.org\/10.3390\/molecules22101642","journal-title":"Molecules"},{"key":"479_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.12691\/ajps-3-1-4","volume":"3","author":"A Ajeet","year":"2015","unstructured":"Ajeet A, Mishra AK, Kumar A (2015) Recent advances in development of sulfonamide derivatives and their pharmacological effects\u2014a review. Am J Pharmacol Sci 3:18\u201324. \n                    https:\/\/doi.org\/10.12691\/ajps-3-1-4","journal-title":"Am J Pharmacol Sci"},{"key":"479_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejmech.2013.03.012","volume":"64","author":"J Lal","year":"2013","unstructured":"Lal J, Sushil K, Gupta D (2013) Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides. Eur J Med Chem 64:579\u2013588. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2013.03.012","journal-title":"Eur J Med Chem"},{"key":"479_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4155\/fmc.14.68","volume":"6","author":"F Carta","year":"2014","unstructured":"Carta F, Supuran CT, Scozzafava A (2014) Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem 6:1149\u20131165. \n                    https:\/\/doi.org\/10.4155\/fmc.14.68","journal-title":"Future Med Chem"},{"key":"479_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1517\/13543776.16.1.27","volume":"16","author":"JY Winum","year":"2006","unstructured":"Winum JY, Scozzafava A, Montero JL, Supuran CT (2006) The sulfamide motif in the design of enzyme inhibitors. Expert Opin Ther Pat 16:27\u201347. \n                    https:\/\/doi.org\/10.1517\/13543776.16.1.27","journal-title":"Expert Opin Ther Pat"},{"key":"479_CR35","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1021\/jm300752n","volume":"55","author":"J Mun","year":"2012","unstructured":"Mun J, Jabbar AA, Devi NS, Yin S, Wang Y, Tan C et al (2012) Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl] hetero aryl sulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and antiproliferative agents. J Med Chem 55:6738\u20136750. \n                    https:\/\/doi.org\/10.1021\/jm300752n","journal-title":"J Med Chem"},{"key":"479_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejmech.2014.08.016","volume":"85","author":"HS Ibrahim","year":"2014","unstructured":"Ibrahim HS, Eldehna WM, Abdel-Aziz HA, Elaasser MM, Abdel-Aziz MM (2014) Improvement of antibacterial activity of some sulfa drugs through linkage to certain phthalazin-1(2H)-one scaffolds. Eur J Med Chem 85:480\u2013486. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2014.08.016","journal-title":"Eur J Med Chem"},{"key":"479_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.arabjc.2012.12.005","volume":"7","author":"M Kumar","year":"2014","unstructured":"Kumar M, Ramasamy K, Manic V, Mishra RK, Abdul Majeed A, DeClercq E et al (2014) Synthesis, antimicrobial, antiproliferative, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylidene amino)-N-substituted benzene sulfonamides. Arab J Chem 7:396\u2013408. \n                    https:\/\/doi.org\/10.1016\/j.arabjc.2012.12.005","journal-title":"Arab J Chem"},{"key":"479_CR38","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/S0960-894X(01)00528-5","volume":"11","author":"K Chibale","year":"2001","unstructured":"Chibale K, Haupt H, Kendrick H, Yardley V, Saravanamuthu A, Fairlamb AH et al (2001) Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine. Bioorg Med Chem Lett 11:2655\u20132657. \n                    https:\/\/doi.org\/10.1016\/S0960-894X(01)00528-5","journal-title":"Bioorg Med Chem Lett"},{"key":"479_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1248\/cpb.58.160","volume":"58","author":"C Camoutsis","year":"2010","unstructured":"Camoutsis C, Geronikaki A, Ciric A, Sokovi\u0107 M, Zoumpoulakis P, Zervou M (2010) Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. Chem Pharm Bull 58:160\u2013167. \n                    https:\/\/doi.org\/10.1248\/cpb.58.160","journal-title":"Chem Pharm Bull"},{"key":"479_CR40","first-page":"726","volume":"10","author":"LC Potey","year":"2017","unstructured":"Potey LC, Marathe R, Sable P (2017) In vitro anti-inflammatory activity of quinoxalinsulfonamides. Int J Chemtech Res 10:726\u2013734","journal-title":"Int J Chemtech Res"},{"key":"479_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bmcl.2017.11.026","volume":"28","author":"SS Pandit","year":"2018","unstructured":"Pandit SS, Kulkarni MR, Pandit YB, Lad NP, Khedk VM (2018) Synthesis and in vitro evaluations of 6-(hetero)-aryl-imidazo[1,2-b]pyridazine-3-sulfonamide\u2019s as an inhibitor of TNF-\u03b1 production. Bioorg Med Chem Lett 28:24\u201330. \n                    https:\/\/doi.org\/10.1016\/j.bmcl.2017.11.026","journal-title":"Bioorg Med Chem Lett"},{"key":"479_CR42","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0968-0896(01)00114-6","volume":"8","author":"B Hu","year":"2001","unstructured":"Hu B, Ellingboe J, Han S, Largis E, Lim K, Malamas M et al (2001) Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human b3 agonists. Bioorg Med Chem 8:2045\u20132059. \n                    https:\/\/doi.org\/10.1016\/S0968-0896(01)00114-6","journal-title":"Bioorg Med Chem"},{"key":"479_CR43","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1021\/ja981792o","volume":"120","author":"WR Roush","year":"1998","unstructured":"Roush WR, Gwaltney SL, Cheng J, Scheidt KA, McKerrow JH, Hansell E (1998) Vinyl sulfonate esters and vinyl sulfonamides: potent, irreversible inhibitors of cysteine proteases. J Am Chem Soc 120:10994\u201310995. \n                    https:\/\/doi.org\/10.1021\/ja981792o","journal-title":"J Am Chem Soc"},{"key":"479_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13065-017-0347-4","volume":"11","author":"MR Aouad","year":"2017","unstructured":"Aouad MR, Mayaba MM, Naqvi A, Bardaweel SK, Alblewi FF, El Ashry EH et al (2017) Design, synthesis, in silico and in vitro antimicrobial screenings of novel 1,2,4-triazoles carrying 1,2,3-triazole scaffold with lipophilic side chain tether. Chem Cent J 11:117\u2013129. \n                    https:\/\/doi.org\/10.1186\/s13065-017-0347-4","journal-title":"Chem Cent J"},{"key":"479_CR45","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s11164-016-2679-4","volume":"43","author":"N Rezki","year":"2017","unstructured":"Rezki N, Mayaba MM, Alblewi FF, El Ashry EH, Aouad MR (2017) Click 1,4-regioselective synthesis, characterization, and antimicrobial screening of novel 1,2,3-triazoles tethering fluorinated 1,2,4-triazole and lipophilic side chain. Res Chem Intermed 43:995\u20131011. \n                    https:\/\/doi.org\/10.1007\/s11164-016-2679-4","journal-title":"Res Chem Intermed"},{"key":"479_CR46","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.5935\/0103-5053.20150196","volume":"10","author":"MR Aouad","year":"2015","unstructured":"Aouad MR (2015) Efficient eco-friendly solvent-free click synthesis and antimicrobial evaluation of new fluorinated 1,2,3-triazoles and their conversion into Schiff Bases. J Braz Chem Soc 10:2105\u20132115. \n                    https:\/\/doi.org\/10.5935\/0103-5053.20150196","journal-title":"J Braz Chem Soc"},{"key":"479_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15257770.2015.1109098","volume":"35","author":"MR Aouad","year":"2016","unstructured":"Aouad MR (2016) Synthesis and antimicrobial screening of novel thioglycosidesanalogs carrying 1,2,3-triazole and 1,3,4-oxadiazole moieties. Nucleosides Nucleotides Nucleic Acids 35:1\u201315. \n                    https:\/\/doi.org\/10.1080\/15257770.2015.1109098","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"479_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00304948.2017.1320515","volume":"49","author":"MR Aouad","year":"2017","unstructured":"Aouad MR (2017) Click synthesis and antimicrobial screening of novel isatin-1,2,3-triazoles with piperidine, morpholine or piperazine moieties. Org Prep Proc Int 49:216\u2013227. \n                    https:\/\/doi.org\/10.1080\/00304948.2017.1320515","journal-title":"Org Prep Proc Int"},{"key":"479_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1515\/acph-2017-0024","volume":"67","author":"N Rezki","year":"2017","unstructured":"Rezki N, Aouad MR (2017) Green ultrasound-assisted three-component click synthesis of novel 1H-1,2,3-triazole carrying benzothiazoles and fluorinated-1,2,4-triazole conjugates and their antimicrobial evaluation. Acta pharm 67:309\u2013324. \n                    https:\/\/doi.org\/10.1515\/acph-2017-0024","journal-title":"Acta pharm"},{"issue":"1","key":"479_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3184\/174751917X14836231670980","volume":"41","author":"L Faraji","year":"2017","unstructured":"Faraji L, Shahkarami S, Nadri H, Moradi A, Saeedi M, Foroumadi A, Ramazani A, Haririan I, Ganjali MR, Shafiee A, Khoobi M (2017) Synthesis of novel benzimidazole and benzothiazole derivatives bearing a 1,2,3-triazole ring system and their acetylcholinesterase inhibitory activity. J Chem Res 41(1):30\u201335. \n                    https:\/\/doi.org\/10.3184\/174751917X14836231670980","journal-title":"J Chem Res"},{"issue":"2","key":"479_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1515\/acph-2016-0014","volume":"66","author":"BGM Youssif","year":"2016","unstructured":"Youssif BGM, Mohamed YAM, Salim MTA, Inagaki F, Mukai Ch, Abdu-Allah HHM (2016) Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus. Acta Pharm 66(2):219\u2013231. \n                    https:\/\/doi.org\/10.1515\/acph-2016-0014","journal-title":"Acta Pharm"},{"key":"479_CR52","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10593-008-0166-6","volume":"44","author":"TI Yaroshenko","year":"2008","unstructured":"Yaroshenko TI, Nakhmanovich AS, Larina LI, Elokhina VN, Amosova SV (2008) Interaction of benzimidazole-2-thion with propargyl bromide and 1,3-dibromopropyne. Chem Heterocycl Compd 44:1129\u20131134. \n                    https:\/\/doi.org\/10.1007\/s10593-008-0166-6","journal-title":"Chem Heterocycl Compd"},{"key":"479_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/00304948.2017.1384262","volume":"49","author":"N Rezki","year":"2017","unstructured":"Rezki N (2017) Green microwave synthesis and antimicrobial evaluation of novel triazoles. Org Prep Proc Int 49:525\u2013541. \n                    https:\/\/doi.org\/10.1080\/00304948.2017.1384262","journal-title":"Org Prep Proc Int"},{"key":"479_CR54","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1469-0691.2000.00142.x","volume":"6","author":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","year":"2000","unstructured":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (2000) Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect 6:509\u2013515","journal-title":"Clin Microbiol Infect"},{"key":"479_CR55","volume-title":"Methods for dilution, antimicrobial susceptibility tests for bacteria that grow aerobically approved standard M7-A5","author":"National Committee for Clinical Laboratory Standards","year":"2000","unstructured":"National Committee for Clinical Laboratory Standards (2000) Methods for dilution, antimicrobial susceptibility tests for bacteria that grow aerobically approved standard M7-A5, 5th edn. Wayne, NCCLS","edition":"5"},{"key":"479_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1568013013359131","volume":"1","author":"CT Supuran","year":"2001","unstructured":"Supuran CT, Scozzafava A (2001) Carbonic anhydrase inhibitors. Curr Med Chem Imm Endoc Metab Agents 1:61\u201397. \n                    https:\/\/doi.org\/10.2174\/1568013013359131","journal-title":"Curr Med Chem Imm Endoc Metab Agents"},{"key":"479_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pa.16.040176.001521","volume":"16","author":"TH Maren","year":"1976","unstructured":"Maren TH (1976) Relations between structure and biological activity of sulphonamides. Annu Rev Pharmacol Toxicol 16:309\u2013327. \n                    https:\/\/doi.org\/10.1146\/annurev.pa.16.040176.001521","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"479_CR58","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0223-5234(97)89847-9","volume":"31","author":"CT Supuran","year":"1996","unstructured":"Supuran CT, Conroy CW, Maren TH (1996) Carbonic anhydrase inhibitors. Synthesis and inhibitory properties of 1,3,4-thiadiazole-2,5-bissulfonamide. Eur J Med Chem 31:843\u2013846. \n                    https:\/\/doi.org\/10.1016\/S0223-5234(97)89847-9","journal-title":"Eur J Med Chem"},{"key":"479_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02659120","volume":"3","author":"WR Chegwidden","year":"1995","unstructured":"Chegwidden WR, Spencer IM (1995) Sulphonamide inhibitors of carbonic anhydrase inhibit the growth of human lymphoma cells in culture. Inflamm pharmacol 3:231\u2013239. \n                    https:\/\/doi.org\/10.1007\/BF02659120","journal-title":"Inflamm pharmacol"},{"key":"479_CR60","unstructured":"Supuran CT, Scozzafava A (2001) Matrix metalloproteinase inhibitors. In proteinase and peptidase inhibition: recent potential targets for drug development. Smith HJ, Simons C, eds. 1st ed. London: Francis & Taylor; p. 35\u201352"},{"key":"479_CR61","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1016\/0006-2952(88)90672-7","volume":"37","author":"RF Branda","year":"1988","unstructured":"Branda RF, McCormack JJ, Perlmutter CA (1988) Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells. Biochem Pharmacol 37:4557\u20134564","journal-title":"Biochem Pharmacol"},{"key":"479_CR62","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1021\/ci050459i","volume":"46","author":"D Biswas","year":"2006","unstructured":"Biswas D, Roy S, Sen S (2006) A simple approach for indexing the oral drug likeness of a compound: discriminating drug like compounds from nondrug like ones. J Chem Inf Model 46:1394\u20131401","journal-title":"J Chem Inf Model"},{"key":"479_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feene PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"479_CR64","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714\u20133717","journal-title":"J Med Chem"},{"key":"479_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55\u201368","journal-title":"J Comb Chem"},{"key":"479_CR66","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623","journal-title":"J Med Chem"},{"key":"479_CR67","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC (2005) A bioavailability score. J Med Chem 48:3164\u20133170. \n                    https:\/\/doi.org\/10.1021\/jm0492002","journal-title":"J Med Chem"},{"key":"479_CR68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1124\/dmd.105.008458","volume":"34","author":"S Ekins","year":"2006","unstructured":"Ekins S, Andreyev S, Ryabov A, Kirillov E, Rakhmatulin EA, Sorokina S et al (2006) A combined approach to drug metabolism and toxicity assessment. Drug Metab Dispos 34:495\u2013503. \n                    https:\/\/doi.org\/10.1124\/dmd.105.008458","journal-title":"Drug Metab Dispos"},{"key":"479_CR69","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/cmdc.200600155","volume":"1","author":"U Norinder","year":"2006","unstructured":"Norinder U, Bergstr\u00f6m CAS (2006) Prediction of ADMET properties. Chem Med Chem 1:920\u2013937. \n                    https:\/\/doi.org\/10.1002\/cmdc.200600155","journal-title":"Chem Med Chem"},{"key":"479_CR70","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"C Feixiong","year":"2012","unstructured":"Feixiong C, Weihua L, Yadi Z, Jie S, Zengrui W, Guixia L (2012) Admetsar: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52:3099\u20133105","journal-title":"J Chem Inf Model"}],"container-title":["Chemistry Central Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-018-0479-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13065-018-0479-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-018-0479-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T05:47:19Z","timestamp":1572587239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-018-0479-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1186\/s13065-018-0479-1","relation":{},"ISSN":["1752-153X"],"issn-type":[{"value":"1752-153X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"110"}}